Your Daily Pharma Scoop: Abeona’s ABO-202, Revance Update, Ionis/Biogen’s New Collaboration – Seeking Alpha
|
Your Daily Pharma Scoop: Abeona's ABO-202, Revance Update, Ionis/Biogen's New Collaboration
Seeking Alpha Analysis focus: Abeona Therapeutics. Today we will discuss Abeona Therapeutics (NASDAQ:ABEO), which is up more than 5% in early trading after announcing that the European Medicines Agency (NYSEMKT:EMA) has granted its gene therapy AB-202 an Orphan Drug … |
